1. Home
  2. DARE vs NCRA Comparison

DARE vs NCRA Comparison

Compare DARE & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • NCRA
  • Stock Information
  • Founded
  • DARE 2015
  • NCRA 2002
  • Country
  • DARE United States
  • NCRA Taiwan
  • Employees
  • DARE N/A
  • NCRA N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • NCRA Farming/Seeds/Milling
  • Sector
  • DARE Health Care
  • NCRA Consumer Staples
  • Exchange
  • DARE Nasdaq
  • NCRA Nasdaq
  • Market Cap
  • DARE 28.6M
  • NCRA 23.0M
  • IPO Year
  • DARE N/A
  • NCRA N/A
  • Fundamental
  • Price
  • DARE $1.91
  • NCRA $1.18
  • Analyst Decision
  • DARE Strong Buy
  • NCRA
  • Analyst Count
  • DARE 2
  • NCRA 0
  • Target Price
  • DARE $10.00
  • NCRA N/A
  • AVG Volume (30 Days)
  • DARE 173.3K
  • NCRA 2.0M
  • Earning Date
  • DARE 11-13-2025
  • NCRA 11-14-2025
  • Dividend Yield
  • DARE N/A
  • NCRA N/A
  • EPS Growth
  • DARE N/A
  • NCRA N/A
  • EPS
  • DARE N/A
  • NCRA N/A
  • Revenue
  • DARE N/A
  • NCRA $13,865,984.00
  • Revenue This Year
  • DARE $5,401.89
  • NCRA N/A
  • Revenue Next Year
  • DARE $6,257.18
  • NCRA N/A
  • P/E Ratio
  • DARE N/A
  • NCRA N/A
  • Revenue Growth
  • DARE N/A
  • NCRA N/A
  • 52 Week Low
  • DARE $1.76
  • NCRA $0.70
  • 52 Week High
  • DARE $9.19
  • NCRA $2.40
  • Technical
  • Relative Strength Index (RSI)
  • DARE 43.71
  • NCRA 37.13
  • Support Level
  • DARE $1.76
  • NCRA $1.04
  • Resistance Level
  • DARE $1.99
  • NCRA $1.33
  • Average True Range (ATR)
  • DARE 0.10
  • NCRA 0.19
  • MACD
  • DARE -0.01
  • NCRA -0.06
  • Stochastic Oscillator
  • DARE 41.44
  • NCRA 9.56

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: